carnosol and Pancreatic-Neoplasms
carnosol has been researched along with Pancreatic-Neoplasms* in 2 studies
Other Studies
2 other study(ies) available for carnosol and Pancreatic-Neoplasms
| Article | Year |
|---|---|
Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells.
Human farnesyl pyrophosphate synthase ( Topics: Antineoplastic Agents; Binding Sites; Biological Products; Cell Line, Tumor; Cell Survival; Computational Biology; Geranyltranstransferase; Humans; Pancreatic Neoplasms; Protein Conformation | 2019 |
Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors.
Receptor tyrosine kinases (RTKs) are pharmaceutically attractive targets due to their fundamental role in tumor formation. The hallmark of pancreatic cancer is its high mortality rate attributed to the existence of cancer stem cell (CSC) subpopulations which result in therapy resistance and recurrence. c-Met is a known pancreatic CSC marker that belongs to the family of RTKs. To surmount the hurdles related to ligand-independent c-Met activation, we aimed to elucidate the inhibitory mechanisms of withaferin A (WA) and carnosol (CA) as two hit phytochemicals against c-Met kinase domain. Both tested compounds attenuated HGF-mediated proliferation across various established c-Met Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Mice; Neoplastic Stem Cells; NIH 3T3 Cells; Pancreatic Neoplasms; Phenotype; Phosphorylation; Phytochemicals; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Signal Transduction; Withanolides | 2018 |